| 000 | 01627 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517233714.0 | ||
| 264 | 0 | _c20190208 | |
| 008 | 201902s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0202796 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSutton, Andrew J | |
| 245 | 0 | 0 |
_aAn early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancer. _h[electronic resource] |
| 260 |
_bPloS one _c2018 |
||
| 300 |
_ae0202796 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdiagnosis |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aCystoscopy _xeconomics |
| 650 | 0 | 4 |
_aDiagnostic Tests, Routine _xeconomics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematuria _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMarkov Chains |
| 650 | 0 | 4 | _aModels, Economic |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdiagnosis |
| 650 | 0 | 4 |
_aUrine _xchemistry |
| 700 | 1 | _aLamont, John V | |
| 700 | 1 | _aEvans, R Mark | |
| 700 | 1 | _aWilliamson, Kate | |
| 700 | 1 | _aO'Rourke, Declan | |
| 700 | 1 | _aDuggan, Brian | |
| 700 | 1 | _aSagoo, Gurdeep S | |
| 700 | 1 | _aReid, Cherith N | |
| 700 | 1 | _aRuddock, Mark W | |
| 773 | 0 |
_tPloS one _gvol. 13 _gno. 8 _gp. e0202796 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0202796 _zAvailable from publisher's website |
| 999 |
_c28759990 _d28759990 |
||